Warfarin and End-Stage Osteoarthritis: Dr. David Liew ( @drdavidliew) #ACR20 https://t.co/hHZTL48DTI https://t.co/X4BDGBOGFq

• https://bit.ly/38T2R8S

#BestACR20Tweets RT @MeralElRamahiMD : When do you think we are going to get a DMARD for OA? 50% or more over age 60 will have osteoarthritis, yet we are yet to discover a promising disease modifying therapy. #ACR20 @ElaineHusniMD

#BestACR20Tweets RT @Janetbirdope : Filgo decreased MRI inflammation of many structures early in Rx in SpA which seems novel says w Maksymowych 5M015 @RheumNow #ACR20 @CRASCRRheum #ACRbest https://t.co/5HQiIettjh https://t.co/NwFMkLIhWw

• https://bit.ly/3lP3dB8

MAGIC Syndrome in Relapsing Polychondritis: Dr. Bella Mehta #ACR20 https://t.co/fjlB2T4o3E https://t.co/OBlccrMhpJ

• https://bit.ly/38LL6bJ

Listen to our Psoriatic Arthritis Panel Discussion podcast with Drs. Artie Kavanaugh, Jack Cush, Eric Ruderman and Alexis Ogdie-Beatty. #ACR20 Listen via the link below or Apple/Android podcasts. https://t.co/BbOyuM4kZV https://t.co/7Y1b6vmYy8

• https://bit.ly/36ttv5H

Check out our #ACR20 video. Dr. Kathryn Dao, ( @KDAO2011) breaks down the impact of exercise on sleep. https://t.co/a9rtO3CVj3 https://t.co/aWVVGJ6Th1

• https://bit.ly/35wGB2A

XRay Bone Erosions in CCP+ Patients with Dr Eric Dein ( @ejdein1) #ACR20 https://t.co/f6RnoExBgk https://t.co/MJCp3sR1UZ

• https://bit.ly/3pyxeHB

Check out of video by Dr. Rachel Tate ( @uptoTate ) titled "Treat to Target in Spondyloarthritis". #ACR20 https://t.co/7ThVtmguFI https://t.co/on9m0qtse3

• https://bit.ly/2UuXcO1

Check out this video on combo therapy v monotherapy (SEAM-RA Trial) with Dr. Richard Conway (@RichardPAConway). #ACR20 https://t.co/iNsmKHSnMq https://t.co/tELmueVEK0

• https://bit.ly/36BsoRv

Watch our #ACR20 video recap titled "Treatment of Dermatomyositis Studies" with Dr Robert Chao (@doctorRBC). Dr. Chao reviews two important abstracts - #0955 and #0958 - on the treatment of dermatomyositis as presented at the 2020 ACR annual meeting. https://t.co/1hiTZQVjlL https://t.co/CW9OGHTuJg

• https://bit.ly/3pEPrnh

#BestACRTweets20 RT @RHEUMarampa : IgG4-RD tx: GCs are mainstay tx starting at 30-40mg/d tapered gradually but 30% of pts will have recurrences Potential therapeutic targets to ⬇GC toxicity ✏B cell/plasmablasts (promising) ✏T cells (anecdotal) #ACR20 https://t.co/htu849kng3

• https://bit.ly/3nCdRvJ

#BestACR20Tweets RT @synovialjoints : New mode of action treatment in AS. The SELECT-AXIS 1 showed Upadacitinib 15mg od showed sustained efficacy over 1 year @RheumNow #ACR20 Abstr#2023 #ACRbest https://t.co/Auo3AMNTDw

• https://bit.ly/3feCeMW

What is the SEAMless transition from combination Etanercept to Methotrexate? Dr. Jonathan Kay takes a deep dive into plenary abstract #0939 presented at #ACR20 annual meeting, reviewing two previous clinical trials that also looked at this question. https://t.co/58raeaE8Mr https://t.co/ZP2P0IZ1Fc

• https://bit.ly/2Ivu32v